Neoplasia
Journal Title
- Neoplasia
ISSN
- E 1476-5586 | P 1522-8002
Publisher
- Elsevier BV
Listed on(Coverage)
| JCR | 2002-2023 |
|---|---|
| SJR | 2000-2020;2022-2023 |
| CiteScore | 2011-2023 |
| SCI | 2010-2019 |
| SCIE | 2010-2024 |
| CC | 2016-2024 |
| SCOPUS | 2017-2024 |
| MEDLINE | 2016-2024 |
| DOAJ | 2017-2024 |
| EMBASE | 2016-2024 |
OA Info.
| OA |
based on the information
|
|---|---|
| Keywords | cancer, tumors, oncology research, medicine |
| Review Process | Anonymous peer review |
| Journal info. pages | |
| Licences | CC BY, CC BY-NC-ND |
| Copyrights | No |
| DOAJ Coverage |
|
| Subject(s) | Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens |
Active
- Active
based on the information
- SCOPUS:2024-10
Country
- USA
Aime & Scopes
- Neoplasia publishes the results of novel investigations in all areas of oncology research. The title Neoplasia was chosen to convey the journal’s breadth, which encompasses the traditional disciplines of cancer research as well as emerging fields and interdisciplinary investigations. Neoplasia is interested in studies describing new molecular and genetic findings relating to the neoplastic phenotype and in laboratory and clinical studies demonstrating creative applications of advances in the basic sciences to risk assessment, prognostic indications, detection, diagnosis, and treatment. In addition to regular Research Reports, Neoplasia also publishes Reviews and Meeting Reports. Neoplasia is committed to ensuring a thorough, fair, and rapid review and publication schedule to further its mission of serving both the scientific and clinical communities by disseminating important data and ideas in cancer research. Neoplasia encourages the free exchange of all clones, cell lines, and biological reagents described in its pages to facilitate the progress of research in order to ultimately provide those fighting neoplastic diseases with new diagnostic, preventative and therapeutic options.